Author:
Kittler Stefan,Slouka Christoph,Pell Andreas,Lamplot Roman,Besleaga Mihail,Ablasser Sarah,Herwig Christoph,Spadiut Oliver,Kopp Julian
Abstract
AbstractIn many industrial sectors continuous processing is already the golden standard to maximize productivity. However, when working with living cells, subpopulation formation causes instabilities in long-term cultivations. In cascaded continuous cultivation, biomass formation and recombinant protein expression can be spatially separated. This cultivation mode was found to facilitate stable protein expression using microbial hosts, however mechanistic knowledge of this cultivation strategy is scarce. In this contribution we present a method workflow to reduce workload and accelerate the establishment of stable continuous processes with E. coli BL21(DE3) exclusively based on bioengineering methods.
Publisher
Springer Science and Business Media LLC
Reference48 articles.
1. Huang, C.-J., Lin, H. & Yang, X. Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements. J. Ind. Microbiol. Biotechnol. 39, 383–399 (2012).
2. Baeshen, M. N. et al. Production of biopharmaceuticals in E. coli: Current scenario and future perspectives. J. Microbiol. Biotechnol. 25, 953–962 (2015).
3. Jia, B. & Jeon, C. O. High-throughput recombinant protein expression in Escherichia coli: Current status and future perspectives. Open Biol. 6, 160196 (2016).
4. Rosano, G. L. & Ceccarelli, E. A. Recombinant protein expression in Escherichia coli: Advances and challenges. Front. Microbiol. 5, 172 (2014).
5. Tegel, H., Ottosson, J. & Hober, S. Enhancing the protein production levels in Escherichia coli with a strong promoter. FEBS J. 278, 729–739 (2011).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献